» Articles » PMID: 12858464

Prevalence of Rheumatic Diseases in Greece: a Cross-sectional Population Based Epidemiological Study. The ESORDIG Study

Abstract

Objective: To assess the prevalence of rheumatic diseases in Greek urban, suburban, and rural adult general populations.

Methods: This cross-sectional population based epidemiological study of rheumatic diseases in Greece (the ESORDIG Study) was conducted on the total adult population of 2 urban, one suburban, and 4 rural communities (8547 subjects), as well as on 2100 out of 5686 randomly selected subjects in one suburban and one rural community. The study, based on a standardized questionnaire and clinical evaluation and laboratory investigation when necessary, was carried out by rheumatologists who visited the target population at their homes. Either established classification criteria or criteria set for the purposes of the study were used for diagnosis.

Results: A total of 8740 subjects participated in the study (response rate 82.1%). The overall age and sex adjusted prevalence (prevalence(asa)) of rheumatic diseases in the total target adult population was 26.9% (95% CI 26.2-27.6), being significantly higher among women (33.7%) than men (19.9%) (p < 0.0005). Disease prevalence(asa) increased significantly with age (p < 0.0005). The most common disease group was low back pain, with a prevalence(asa) of 11.0%, followed by symptomatic peripheral osteoarthritis (7.9%), neck pain (4.8%), miscellaneous rheumatic disorders (4.4%), soft tissue rheumatism disorders (4.3%), and inflammatory rheumatic disease (2.1%). Logistic regression analysis showed a significant positive association of female or male sex, age >or= 50 years, high body mass index, low level of education, moderate or heavy alcohol consumption, and high socioeconomic level with particular diseases or disease groups.

Conclusion: These findings indicate rheumatic diseases are very common in the general adult population of Greece; 26.9% of adults currently have active or chronic rheumatic disease in remission.

Citing Articles

Evaluation of fibromyalgia frequency and quality of life in Notalgia paresthetica patients.

Sari N, Kulakli S, Oguz I, Aksan B, Sari I Arch Dermatol Res. 2024; 316(6):317.

PMID: 38822886 PMC: 11144133. DOI: 10.1007/s00403-024-03027-8.


Early Diagnosis of Fibromyalgia Using Surface-Enhanced Raman Spectroscopy Combined with Chemometrics.

Bao H, Hackshaw K, Castellvi S, Wu Y, Gonzalez C, Nuguri S Biomedicines. 2024; 12(1).

PMID: 38255238 PMC: 10813180. DOI: 10.3390/biomedicines12010133.


Beyond the horizon: Innovations and future directions in axial-spondyloarthritis.

Venerito V, Vescovo S, Lopalco G, Proft F Arch Rheumatol. 2023; 38(4):491-511.

PMID: 38125058 PMC: 10728740. DOI: 10.46497/ArchRheumatol.2023.10580.


Cost Effectiveness of Tofacitinib for the Treatment of Active Ankylosing Spondylitis in Greece.

Gourzoulidis G, Solakidi A, Psarra M, Nikitopoulou E, Tzanetakos C Clin Drug Investig. 2023; 44(1):59-69.

PMID: 38104048 DOI: 10.1007/s40261-023-01333-z.


Perceived treatment satisfaction in patients with systemic rheumatic diseases treated with biologic therapies: results of a self-reported survey.

Ermeidis C, Dimitroulas T, Pourzitaki C, Voulgari P, Kouvelas D Rheumatol Int. 2023; 43(6):1151-1159.

PMID: 36786872 PMC: 9925926. DOI: 10.1007/s00296-023-05280-y.